SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
SIOX
Delisted
SIOX was delisted on the 22nd of March, 2023.
41 hedge funds and large institutions have $12.1M invested in Sio Gene Therapies Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
41
Holding in Top 10
–
Calls
$35K
Puts
$30K
Top Buyers
| 1 | +$117K | |
| 2 | +$60K | |
| 3 | +$48.8K | |
| 4 |
Two Sigma Investments
New York
|
+$43.5K |
| 5 |
CIA
Cladis Investment Advisory
Billings,
Montana
|
+$28.1K |
Top Sellers
| 1 | -$2.37M | |
| 2 | -$494K | |
| 3 | -$243K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$215K |
| 5 |
Millennium Management
New York
|
-$190K |